AAD 2022 HAIRCARE ROUTINE TO TREAT THE TELOGEN EFFLUVIUM ASSOCIATED TO POST COVID-19 INFECTION

  • 10min (reading time)
  • Mar. 2023
  • Supported by
  • Laboratoires Vichy

INTRODUCTION

  • Telogen effluvium (TE) is characterized by diffuse hair shedding 2-3 months after a stress factor such as fever, hypoxia, inflammation (Interleukin-6) and medications

  • Need for mechanical ventilation may play a role in the development and severity of TE caused by COVID-19